Intravenous immunoglobulin for presumed viral myocarditis in children and adults (Q24244970)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Intravenous immunoglobulin for presumed viral myocarditis in children and adults (English)

0 references

1 reference

4

Terry P Klassen

0 references

Lisa Hartling

series ordinal

2

object named as

Lisa Hartling

0 references

author name string

Joan Robinson

series ordinal

1

0 references

Ben Vandermeer

series ordinal

3

0 references

publication date

24 January 2005

0 references

published in

0 references

cites work

Severe Coxsackie virus B infection in preterm newborns treated with pleconaril.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

An approach to the treatment of pediatric myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

Prognostic determinants in conventionally treated myocarditis and perimyocarditis--focus on antimyolemmal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

Diagnosis and treatment of pediatric viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

Dilated cardiomyopathies as a cause of congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

Giant cell myocarditis due to coxsackie B2 virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

High-dose intravenous immunoglobulin in the treatment of acute myocarditis. A case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

A cluster of fulminant myocarditis cases in children, Baltimore, Maryland, 1997

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

Gamma-globulin treatment of acute myocarditis in the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

Variance imputation for overviews of clinical trials with continuous response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

7 January 2021

Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

7 January 2021

Intravenous immune globulin in the therapy of peripartum cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

7 January 2021

Fulminant and acute lymphocytic myocarditis: the prognostic value of clinicopathological classification

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

7 January 2021

Diagnosis and classification of myocarditis by endomyocardial biopsy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

7 January 2021

The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

7 January 2021

Predictors of disease course in patients with acute myocarditis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

7 January 2021

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

7 January 2021

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

7 January 2021

Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

7 January 2021

Therapy with immunoglobulin suppresses myocarditis in a murine coxsackievirus B3 model. Antiviral and anti-inflammatory effects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

7 January 2021

Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

7 January 2021

Advances in the understanding of myocarditis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

7 January 2021

High-dose immunoglobulin G therapy for fulminant myocarditis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004370.PUB2

7 January 2021